Softgel Capsules Market Size & Growth Forecast 2027–2036, By Segments (End-use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Softgel Capsules Market size stood at USD 9.1 billion in 2026 and is predicted to grow at a 7.51% CAGR from 2027 to 2036, exceeding USD 18.77 billion by 2036. The industry revenue for 2027 is estimated at USD 9.68 billion.
Get more details on this report
Request Free Sample ReportSoftgel Capsules Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through its mature pharmaceutical and nutraceutical ecosystem, advanced encapsulation capabilities, and strong demand for convenient dosage formats.
- Asia Pacific is projected to grow at a 7.91% CAGR, supported by rising supplement consumption, pharmaceutical production, and broader healthcare product access.
Segment Momentum
- Nutraceutical companies held a 39.96% share in 2026, supported by strong demand for softgels in oil-based and combination formulations that benefit from dosage precision, product differentiation, and consumer-friendly delivery.
- Non-animal-based softgels are the fastest-growing type segment as manufacturers expand plant-based and alternative formulation offerings that align with evolving product positioning and broader consumer preferences.
Market Expansion Drivers
- Rising nutraceutical consumption and dietary supplement adoption driving softgel demand globally.
- Increasing demand for plant-based and vegan capsule formats supporting formulation innovation.
- Expansion of advanced drug delivery systems improving bioavailability and controlled release capabilities.
Leading Market Participants
- Leading players in the softgel capsules market include Fuji Capsules Co Ltd (Japan), Sirio Pharma Co., Ltd. (China), Captek Softgel International Inc. (United States), Patheon (Thermo Fisher Scientific) (United States), Catalent Inc. (United States), EuroCaps Ltd (United Kingdom), Aenova Group (Germany), Capsugel (Lonza Group) (Switzerland), Procaps Laboratories Inc. (Colombia), Soft Gel Technologies Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 9.1 billion
- 2027 Estimated Market Size: USD 9.68 billion.
- Projected Market Size: USD 18.77 billion by 2036
- Growth Forecast: 7.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Nutraceutical Companies (End-use) | Gelatin-Based/Animal-Based (Type) | Vitamin and Dietary Supplement (Application)
- Emerging Opportunity Segment: Nutraceutical Companies (End-use) | Non-Animal-Based (Type) | Health Supplement (Application)
Market Growth Drivers and Industry Trends
Rising nutraceutical consumption and dietary supplement adoption driving softgel demand globally
Growing consumer interest in preventive health, wellness, and dietary supplementation is supporting the softgel capsules market by increasing demand for convenient dosage formats for vitamins, minerals, herbal extracts, and other nutraceutical ingredients. Softgels offer benefits such as ease of swallowing, consistent dosing, and suitability for oil-based or lipid-soluble formulations, making them widely applicable across supplement categories. Their smooth encapsulated format also supports consumer acceptance of products designed for regular use, particularly where manufacturers seek dosage forms that combine portability with efficient ingredient delivery.
Increasing demand for plant-based and vegan capsule formats supporting formulation innovation
Demand for plant-based and vegan dosage formats is encouraging manufacturers to develop alternatives that align with changing dietary preferences and clean-label positioning. The softgel capsules market is responding through greater formulation innovation around non-animal-derived shell materials and compatible encapsulation processes, allowing supplement and pharmaceutical products to address consumers seeking alternatives to conventional gelatin-based formats. This shift also expands formulation possibilities for manufacturers targeting specialized consumer segments while maintaining the familiar convenience and appearance associated with softgel delivery systems.
Expansion of advanced drug delivery systems improving bioavailability and controlled release capabilities
Advances in formulation science are expanding the role of softgels beyond conventional encapsulation by supporting delivery systems designed to improve absorption and optimize the release of active ingredients. The softgel capsules market benefits from technologies that can enhance the solubility and bioavailability of poorly water-soluble compounds, particularly for active pharmaceutical ingredients with challenging absorption characteristics. Greater control over formulation characteristics can also help support sustained or modified release approaches, providing manufacturers with additional options for developing dosage forms tailored to specific therapeutic requirements.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising nutraceutical consumption and dietary supplement adoption driving softgel demand globally | 2.10% | Moderate | North America, Asia Pacific | High | Near Term |
| Increasing demand for plant-based and vegan capsule formats supporting formulation innovation | 1.70% | Moderate | Europe, North America | High | Mid Term |
| Expansion of advanced drug delivery systems improving bioavailability and controlled release capabilities | 1.50% | High | North America, Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the softgel capsules market in 2026, reflecting strong pharmaceutical and nutraceutical manufacturing capabilities, established consumer demand for convenient dosage formats, and widespread availability of advanced drug delivery technologies. The region's well-developed healthcare system and mature dietary supplement industry support consistent demand for softgel formulations across therapeutic and wellness applications. Manufacturers are also focusing on improved formulation performance, enhanced bioavailability, and consumer-friendly delivery formats, supporting continued product adoption. Growing interest in preventive health and nutritional supplementation further contributes to demand, while established regulatory and manufacturing frameworks facilitate the development and commercialization of softgel products.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, supported by expanding pharmaceutical manufacturing, rising healthcare awareness, and increasing consumption of nutritional supplements. Growing middle-class populations and improving access to healthcare are encouraging greater demand for convenient oral dosage forms across both therapeutic and wellness applications. The region is also strengthening its pharmaceutical production capabilities, creating opportunities for greater adoption of advanced encapsulation technologies. Increasing consumer interest in preventive healthcare, combined with expanding distribution networks and rising demand for dietary and functional supplements, is expected to support sustained market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Manufacturing FocusGermany supports the softgel capsules market through stringent pharmaceutical quality standards and specialized manufacturing expertise. German producers increasingly focus on premium encapsulation technologies, regulatory compliance, and customized formulations for healthcare and nutraceutical customers.
France 🇫🇷
Premium Nutraceutical DevelopmentFrance supports the softgel capsules market through premium nutritional supplements and pharmaceutical-grade production. French manufacturers prioritize natural ingredients, formulation quality, and product differentiation to meet demand from health-conscious consumers and regulated healthcare sectors.
Italy 🇮🇹
Specialized Contract ProductionItaly contributes to the softgel capsules market through flexible manufacturing capabilities serving pharmaceutical and nutraceutical brands. Italian producers focus on customized encapsulation services, production efficiency, and compliance with international quality requirements for export-oriented business.
Japan 🇯🇵
Functional Health ApplicationsJapan strengthens the softgel capsules market by integrating encapsulation technologies with functional nutrition and pharmaceutical innovation. Japanese manufacturers emphasize formulation stability, ingredient compatibility, and products tailored to preventive healthcare and aging-related consumer demand.
South Korea 🇰🇷
Beauty and Wellness IntegrationSouth Korea advances the softgel capsules market by combining nutraceutical innovation with beauty, wellness, and functional health products. Companies in South Korea invest in differentiated formulations and premium consumer offerings that align with evolving dietary supplement preferences.
United States 🇺🇸
Innovation-Driven FormulationThe U.S. softgel capsules market emphasizes advanced formulations, consumer-centric nutraceutical products, and contract manufacturing capabilities. Companies in the U.S. continue to prioritize bioavailability improvements, clean-label ingredients, and scalable production for pharmaceutical and dietary supplement applications.
Segment Leadership and Growth Trends
Softgel Capsules Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Nutraceutical Companies (Largest & Fastest-Growing Segment)
Nutraceutical companies segment led the softgel capsules market in 2026, accounting for a 39.96% share, supported by the growing use of softgel formats for vitamins, botanical extracts, oils, and other wellness-oriented formulations. Softgels offer advantages such as convenient consumption, effective encapsulation of liquid and oil-based ingredients, and improved product appeal, making them well suited to nutraceutical formulations. Their smooth dosage form and compatibility with diverse active ingredients also support consumer acceptance and product differentiation. As preventive health and daily supplementation become increasingly important purchasing considerations, nutraceutical manufacturers continue to favor delivery formats that combine formulation flexibility with ease of use, reinforcing this segment's leading position and growth momentum.
Type Segment Analysis: Gelatin-Based/Animal-Based (Largest Segment) vs Non-Animal-Based (Fastest-Growing Segment)
Holding the largest share of the softgel capsules market, the gelatin-Based/Animal-based segment represented the leading type in 2026. Its established manufacturing infrastructure, proven encapsulation performance, and compatibility with a broad range of formulations continue to support widespread adoption. Gelatin provides desirable shell characteristics, including flexibility, durability, and effective protection of encapsulated ingredients, which makes it a well-established choice across pharmaceutical and nutraceutical applications. Familiarity among manufacturers and established processing practices further strengthen its position within the softgel industry.
Non-Animal-Based softgels are gaining momentum as formulation preferences increasingly reflect demand for plant-derived and animal-free alternatives. These capsules provide an option for consumers and manufacturers seeking products aligned with vegetarian, vegan, or specific dietary requirements while maintaining the convenience associated with softgel delivery. Continued advances in alternative shell materials and formulation technologies are improving the practicality of non-animal-based capsules across a broader range of applications. This shift toward cleaner and more inclusive product formats is supporting faster adoption of the segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organizations | Nutraceutical Companies | Nutraceutical Companies |
| Type | Gelatin-Based/Animal-Based, Non-Animal-Based | Gelatin-Based/Animal-Based | Non-Animal-Based |
| Application | Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy | Vitamin and Dietary Supplement | Health Supplement |
Competitive Landscape and Market Positioning
Key companies in the softgel capsules market:
1. Fuji Capsules Co Ltd (Japan)
2. Sirio Pharma Co. Ltd. (China)
3. Captek Softgel International Inc. (United States)
4. Patheon (Thermo Fisher Scientific) (United States)
5. Catalent Inc. (United States)
6. EuroCaps Ltd (United Kingdom)
7. Aenova Group (Germany)
8. Capsugel (Lonza Group) (Switzerland)
9. Procaps Laboratories Inc. (Colombia)
10. Soft Gel Technologies Inc. (United States)
The softgel capsules market is witnessing strong product innovation focused on plant-based formulations, improved bioavailability, and clean-label supplement solutions. Growing consumer preference for convenient dosage formats and sustainable manufacturing processes is encouraging companies to diversify their product portfolios and enhance production efficiency.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Fuji Capsules Co Ltd (Japan) | |||||||
| Sirio Pharma Co. Ltd. (China) | |||||||
| Captek Softgel International Inc. (United States) | |||||||
| Patheon (Thermo Fisher Scientific) (United States) | |||||||
| Catalent Inc. (United States) | |||||||
| EuroCaps Ltd (United Kingdom) | |||||||
| Aenova Group (Germany) | |||||||
| Capsugel (Lonza Group) (Switzerland) | |||||||
| Procaps Laboratories Inc. (Colombia) | |||||||
| Soft Gel Technologies Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Roquette | Apr-26 | Roquette expanded its consumer healthcare portfolio, offering integrated capabilities in plant-based ingredients and excipients to support CDMO and supplement customers. This strategic move aims to streamline product development cycles from formulation to commercial launch, strengthening the company's position as a critical supply chain partner for manufacturers of softgel and nutraceutical products. |
| Jupiter Neurosciences | Mar-25 | Jupiter Neurosciences entered a strategic manufacturing partnership with Catalent to produce clinical-stage batches of JOTROL. By utilizing Catalent’s specialized softgel formulation and production expertise, the company is advancing its therapeutic candidate through clinical trials, demonstrating the reliance on contract manufacturing to achieve scalable, high-quality development of complex softgel-based drug delivery systems. |
| OB Holdings Bhd | Oct-24 | OB Holdings Bhd initiated a major manufacturing expansion with the construction of a new facility in Serendah, Selangor. This investment is set to double the company's annual production capacity for dietary supplements and fortified foods, directly addressing increasing market demand and enhancing its competitive manufacturing footprint within the Southeast Asian nutraceutical supply chain. |
| GELITA | Jul-24 | GELITA introduced advanced anti-crosslinking solutions designed to mitigate stability issues inherent in gelatin-based softgel manufacturing. By addressing these performance challenges, the technology allows manufacturers to improve product shelf-life and quality consistency, providing a critical technical enhancement to support the large-scale production of stable softgel dosages for both pharmaceutical and nutraceutical applications. |
| Roquette | May-24 | Roquette launched Lycagel Flex, a pea starch-based premix designed as a vegan alternative for softgel formulation. This product innovation provides formulators with a robust plant-based option to replace traditional gelatin, facilitating the development of vegetarian-friendly delivery systems and expanding the range of functional excipients available for the growing consumer-driven dietary supplement market. |
| Sirio Pharma | Jan-23 | Sirio Pharma finalized the acquisition of Best Formulations, a significant move to consolidate its manufacturing footprint in plant-based softgels and gummies. This strategic integration expanded the company’s global production capacity, strengthened its R&D resources, and diversified its product portfolio, allowing Sirio Pharma to capture a larger share of the contract manufacturing market for nutritional supplements. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Softgel Capsules Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Fill Material | Liquid Fill, Suspension Fill, Semi-Solid Fill, Powder & Granule Fill |
| Release Profile | Immediate-Release, Enteric-Release, Sustained-Release, Controlled-Release |
| Distribution Channel | Direct Sales, Pharmaceutical & Medical Distributors, Retail Pharmacies & Drugstores, E-Commerce |
Softgel Capsules Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Contract Manufacturing and CDMO Landscape Assessment |
|
| Gelatin and Plant-Based Capsule Transition Analysis |
|
| Brand Positioning and Private Label Opportunity Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow much is the softgel capsules market worth?
What is the expected industry size of softgel capsules by 2036?
How is growing nutraceutical adoption driving expansion in the softgel capsules market?
Why are plant-based capsule technologies becoming a strategic focus in the softgel capsules market?
Why do nutraceutical companies lead the softgel capsules market?
What is driving growth in non-animal-based softgel capsules?
Which factors maintain North America’s lead in the softgel capsules market?
How is Asia Pacific expanding opportunities in the softgel capsules market?
What are the key competitors in the softgel capsules landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization